CLINICAL_TRIALS
trial_result
· 2017-02-23
Clinical Trial Update: Ruxolitinib in Patients With Breast Cancer [Phase 2]
Summary
A Phase 2 trial of ruxolitinib in patients with breast cancer was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-02-23